{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:36:50Z","timestamp":1747741010730,"version":"3.37.3"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Global Medical Foundation"},{"name":"Cancer Information and Population Health Resource"},{"DOI":"10.13039\/100008615","name":"UNC Lineberger Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Cancer Research Fund"},{"name":"North Carolin"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI U01 CA254832-03S1"],"award-info":[{"award-number":["NCI U01 CA254832-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victoria\u2019s Secret and Pelotonia","award":["22-20-73-ROBE"],"award-info":[{"award-number":["22-20-73-ROBE"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Inequities in guideline-concordant treatment receipt contribute to worse survival in Black patients with breast cancer. Inequity-reduction interventions (eg, navigation, bias training, tracking dashboards) can close such treatment gaps. We simulated the population-level impact of statewide implementation of inequity-reduction interventions on racial breast cancer inequities in North Carolina.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using registry-linked multipayer claims data, we calculated inequities between Black and White patients receiving endocrine therapy (n\u2009=\u200912\u200a033) and chemotherapy (n\u2009=\u20091819). We then built cohort-stratified (endocrine therapy and chemotherapy) and race-stratified Markov models to simulate the potential increase in the proportion of patients receiving endocrine therapy or chemotherapy and subsequent improvements in breast cancer outcomes if inequity-reducing intervention were implemented statewide. We report uncertainty bounds representing 95% of simulation results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 75.6% and 72.1% of Black patients received endocrine therapy and chemotherapy, respectively, over the 2006-2015 and 2004-2015 periods (vs 79.3% and 78.9% of White patients, respectively). Inequity-reduction interventions could increase endocrine therapy and chemotherapy receipt among Black patients to 89.9% (85.3%, 94.6%) and 85.7% (80.7%, 90.9%). Such interventions could also decrease 5-year and 10-year breast cancer mortality gaps from 3.4 to 3.2 (3.0, 3.3) and from 6.7 to 6.1 (5.9, 6.4) percentage points in the endocrine therapy cohorts and from 8.6 to 8.1 (7.7, 8.4) and from 8.2 to 7.8 (7.3, 8.1) percentage points in the chemotherapy cohorts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Inequity-focused interventions could improve cancer outcomes for Black patients, but they would not fully close the racial breast cancer mortality gap. Addressing other inequities along the cancer continuum (eg, screening, pre- and postdiagnosis risk factors) is required to achieve full equity in breast cancer outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djae019","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T06:07:07Z","timestamp":1706422027000},"page":"902-910","source":"Crossref","is-referenced-by-count":2,"title":["Simulating the population impact of interventions to reduce racial gaps in breast cancer treatment"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-2503","authenticated-orcid":false,"given":"Juan","family":"Yanguela","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford E","family":"Jackson","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-0177","authenticated-orcid":false,"given":"Katherine E","family":"Reeder-Hayes","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"},{"name":"Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mya L","family":"Roberson","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill , NC, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4188-9785","authenticated-orcid":false,"given":"Gabrielle B","family":"Rocque","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham , AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzy-Mey","family":"Kuo","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"},{"name":"School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D","family":"Baggett","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"},{"name":"Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Green","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Laurie-Zehr","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie B","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill , NC, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill , NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"issue":"6","key":"2024060717234293300_djae019-B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3322\/caac.21412","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J Clin"},{"year":"2024","author":"Centers for Disease Control and Prevention","key":"2024060717234293300_djae019-B2"},{"year":"2023","author":"National Cancer Institute","key":"2024060717234293300_djae019-B3"},{"issue":"21","key":"2024060717234293300_djae019-B4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"2024060717234293300_djae019-B5","first-page":"127","article-title":"Histological characteristics of breast carcinoma in blacks and whites. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the","volume":"3","author":"Chen","year":"1994","journal-title":"Am Soc Prev Oncol"},{"issue":"12","key":"2024060717234293300_djae019-B6","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/cncr.20279","article-title":"Racial differences in the expression of cell cycle\u2013regulatory proteins in breast carcinoma: study of young African American and white women in Atlanta, Georgia","volume":"100","author":"Porter","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"2024060717234293300_djae019-B7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/jnci\/djx135","article-title":"Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study","volume":"110","author":"Troester","year":"2018","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"2","key":"2024060717234293300_djae019-B8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jacr.2016.07.034","article-title":"Racial disparities in screening mammography in the United States: a systematic review and meta-analysis","volume":"14","author":"Ahmed","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"2024060717234293300_djae019-B9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","article-title":"Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research","volume":"18","author":"Wheeler","year":"2013","journal-title":"Oncologist"},{"year":"2016","author":"Howlader","key":"2024060717234293300_djae019-B10"},{"issue":"2","key":"2024060717234293300_djae019-B11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.soncn.2015.02.005","article-title":"Health disparities across the breast cancer continuum","volume":"31","author":"Reeder-Hayes","year":"2015","journal-title":"Semin Oncol Nurs"},{"issue":"10","key":"2024060717234293300_djae019-B12","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-016-5486-7","article-title":"Time to treatment: measuring quality breast cancer care","volume":"23","author":"Polverini","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2024060717234293300_djae019-B13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamasurg.2013.1680","article-title":"Delay in surgical treatment and survival after breast cancer diagnosis in young women by race\/ethnicity","volume":"148","author":"Smith","year":"2013","journal-title":"JAMA Surg"},{"issue":"8","key":"2024060717234293300_djae019-B14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamasurg.2014.23","article-title":"Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer","volume":"149","author":"Black","year":"2014","journal-title":"JAMA Surg"},{"issue":"3","key":"2024060717234293300_djae019-B15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10549-011-1398-1","article-title":"Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer","volume":"128","author":"Reeder-Hayes","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2024060717234293300_djae019-B16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10549-012-1955-2","article-title":"Structural\/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients","volume":"133","author":"Wheeler","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2024060717234293300_djae019-B17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/MLR.0b013e31819e1fe7","article-title":"Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?","volume":"47","author":"Keating","year":"2009","journal-title":"Med Care"},{"issue":"9","key":"2024060717234293300_djae019-B18","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/cncr.26542","article-title":"Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California","volume":"118","author":"Parise","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"2024060717234293300_djae019-B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.annepidem.2011.10.001","article-title":"Characteristics associated with the initiation of radiation therapy after breast-conserving surgery among African American and white women diagnosed with early-stage breast cancer in Maryland, 2000-2006","volume":"22","author":"Royak-Schaler","year":"2012","journal-title":"Ann Epidemiol"},{"issue":"2","key":"2024060717234293300_djae019-B20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10549-018-4909-5","article-title":"Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis","volume":"172","author":"Green","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"2024060717234293300_djae019-B21","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1200\/JClinOncol.2005.12.633","article-title":"Racial disparities in treatment and survival among women with early-stage breast cancer","volume":"23","author":"Hershman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"17","key":"2024060717234293300_djae019-B22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1200\/JClinOncol.2015.65.8716","article-title":"Disparities in use of human epidermal growth hormone receptor 2\u2013targeted therapy for early-stage breast cancer","volume":"34","author":"Reeder-Hayes","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"2024060717234293300_djae019-B23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cncr.27831","article-title":"Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race\/ethnicity and education within the National Comprehensive Cancer Network","volume":"119","author":"Freedman","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"2024060717234293300_djae019-B24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-014-2968-9","article-title":"Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy","volume":"145","author":"Freedman","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2024060717234293300_djae019-B25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10549-014-2957-z","article-title":"Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer","volume":"145","author":"Reeder-Hayes","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"2024060717234293300_djae019-B26","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JClinOncol.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients","volume":"28","author":"Hershman","year":"2010","journal-title":"J Clin Oncol"},{"key":"2024060717234293300_djae019-B27","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","article-title":"Racial\/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review","volume":"105(Suppl 3)","author":"Roberts","year":"2015","journal-title":"Am J Public Health"},{"issue":"5","key":"2024060717234293300_djae019-B28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jnma.2019.03.001","article-title":"A multi-faceted intervention aimed at Black-White disparities in the treatment of early stage cancers: the ACCURE pragmatic quality improvement trial","volume":"112","author":"Cykert","year":"2020","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"2024060717234293300_djae019-B29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/cncr.28450","article-title":"Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study","volume":"120","author":"Ramirez","year":"2014","journal-title":"Cancer"},{"issue":"23","key":"2024060717234293300_djae019-B30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/jnci\/djn387","article-title":"A tracking and feedback registry to reduce racial disparities in breast cancer care","volume":"100","author":"Bickell","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2024060717234293300_djae019-B31","doi-asserted-by":"publisher","first-page":"dju115","DOI":"10.1093\/jnci\/dju115","article-title":"Impact of patient navigation on timely cancer care: the Patient Navigation Research Program","volume":"106","author":"Freund","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2024060717234293300_djae019-B32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JOP.2015.008946","article-title":"Patient navigation as a model to increase participation of African Americans in cancer clinical trials","volume":"12","author":"Fouad","year":"2016","journal-title":"J Oncol Pract"},{"issue":"12","key":"2024060717234293300_djae019-B33","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1002\/cncr.25823","article-title":"Patient navigation for American Indians undergoing cancer treatment: utilization and impact on care delivery in a regional healthcare center","volume":"117","author":"Guadagnolo","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"2024060717234293300_djae019-B34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1513\/AnnalsATS.201402-055OC","article-title":"Cultural factors associated with racial disparities in lung cancer care","volume":"11","author":"Lin","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"31","key":"2024060717234293300_djae019-B35","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1200\/JClinOncol.2009.22.9773","article-title":"Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust","volume":"27","author":"Bickell","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024060717234293300_djae019-B36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1200\/JClinOncol.2005.03.1955","article-title":"Racial differences in trust and lung cancer patients\u2019 perceptions of physician communication","volume":"24","author":"Gordon","year":"2006","journal-title":"J Clin Oncol"},{"issue":"23","key":"2024060717234293300_djae019-B37","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1001\/jama.2010.793","article-title":"Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer","volume":"303","author":"Cykert","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"2024060717234293300_djae019-B38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SLA.0000000000005191","article-title":"Reporting on race and racial disparities in breast cancer: the neglect of racism as a driver of inequitable care","volume":"277","author":"Loehrer","year":"2023","journal-title":"Ann Surg"},{"issue":"3","key":"2024060717234293300_djae019-B39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-019-05340-7","article-title":"Social determinants of breast cancer risk, stage, and survival","volume":"177","author":"Coughlin","year":"2019","journal-title":"Breast Cancer Res Treat"},{"year":"2023","author":"UNC Lineberger Comprehensive Cancer Center","key":"2024060717234293300_djae019-B40"},{"issue":"21","key":"2024060717234293300_djae019-B41","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1200\/JClinOncol.2008.16.5068","article-title":"American society. of clinical oncology\/national comprehensive cancer network quality measures","volume":"26","author":"Desch","year":"2008","journal-title":"J Clin Oncol"},{"key":"2024060717234293300_djae019-B42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JClinOncol.2022.40.28_suppl.139","article-title":"Measuring geographic variation in quality and equity of breast cancer care. Presented at the 2022 American Society of Oncology (ASCO) Quality Care Symposium. September 2020. Chicago, Illinois","volume":"40(suppl 28)","author":"Reeder-Hayes","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"2024060717234293300_djae019-B43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"issue":"9472","key":"2024060717234293300_djae019-B44","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Group","year":"2005","journal-title":"The Lancet"},{"issue":"9814","key":"2024060717234293300_djae019-B45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials","volume":"379","author":"EBCTC Group","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"2024060717234293300_djae019-B46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/humrep\/deab246","article-title":"The relation of number of childbirths with age at natural menopause: a population study of 310\u200a147 women in Norway","volume":"37","author":"Gottschalk","year":"2022","journal-title":"Hum Reprod"},{"issue":"10001","key":"2024060717234293300_djae019-B47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Group EBCTC","year":"2015","journal-title":"Lancet"},{"key":"2024060717234293300_djae019-B48","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"issue":"3","key":"2024060717234293300_djae019-B49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer","volume":"6","author":"Ko","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"2024060717234293300_djae019-B50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1188\/05.ONF.250-256","article-title":"Post-treatment symptoms among ethnic minority breast cancer survivors","volume":"32","author":"Eversley","year":"2005","journal-title":"Oncology Nursing Forum"},{"issue":"3","key":"2024060717234293300_djae019-B51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-016-3965-y","article-title":"Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors","volume":"159","author":"Pinheiro","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2024060717234293300_djae019-B52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/GCO.0b013e3280117cf8","article-title":"Racial\/ethnic disparities in breast and gynecologic cancer treatment and outcomes","volume":"19","author":"Tammemagi","year":"2007","journal-title":"Curr Opin Obstetr Gynecol"},{"key":"2024060717234293300_djae019-B53","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1200\/EDBK_319929","article-title":"Disparities in breast cancer associated with African American identity","volume":"41","author":"Stringer-Reasor","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"24","key":"2024060717234293300_djae019-B54","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","article-title":"Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"16","key":"2024060717234293300_djae019-B55","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1001\/jama.287.16.2106","article-title":"Survival of Blacks and Whites after a cancer diagnosis","volume":"287","author":"Bach","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"2024060717234293300_djae019-B56","doi-asserted-by":"publisher","first-page":"e210514","DOI":"10.1001\/jamahealthforum.2021.0514","article-title":"Why adopting a national paid sick leave law is critical to health and to reducing racial and socioeconomic disparities\u2014long past due","volume":"2","author":"Heymann","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"3","key":"2024060717234293300_djae019-B57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40615-020-00817-4","article-title":"Assessing perceived discrimination as reported by black and white women diagnosed with breast cancer","volume":"8","author":"Sutton","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"issue":"7","key":"2024060717234293300_djae019-B58","doi-asserted-by":"publisher","first-page":"e2220908","DOI":"10.1001\/jamanetworkopen.2022.20908","article-title":"Association between residence in historically redlined districts indicative of structural racism and racial and ethnic disparities in breast cancer outcomes","volume":"5","author":"Plascak","year":"2022","journal-title":"JAMA Network Open"},{"issue":"1","key":"2024060717234293300_djae019-B59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/heq.2021.0041","article-title":"Structural racism and triple-negative breast cancer among black and white women in the United States","volume":"6","author":"Eldridge","year":"2022","journal-title":"Health Equity"},{"issue":"13","key":"2024060717234293300_djae019-B60","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1200\/JClinOncol.21.02004","article-title":"Linking structural racism and discrimination and breast cancer outcomes: a social genomics approach","volume":"40","author":"Carlos","year":"2022","journal-title":"J Clin Oncol Offic J Am Soc Clin Oncol"},{"issue":"4","key":"2024060717234293300_djae019-B61","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/SLA.0000000000005375","article-title":"Structural racism and breast cancer-specific survival: impact of economic and racial residential segregation","volume":"275","author":"Goel","year":"2022","journal-title":"Ann Surg"},{"issue":"6","key":"2024060717234293300_djae019-B62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/cncr.34573","article-title":"Race, geography, and risk of breast cancer treatment delays: a population-based study 2004\u20132015","volume":"129","author":"Reeder-Hayes","year":"2023","journal-title":"Cancer"},{"key":"2024060717234293300_djae019-B63","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1245\/s10434-022-11576-3","article-title":"The role of safety-net hospitals in reducing disparities in breast cancer care","volume":"29","author":"Crown","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"2024060717234293300_djae019-B64","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1002\/cncr.33137","article-title":"Quality of care at safety-net hospitals and the impact on pay-for-performance reimbursement","volume":"126","author":"Sarkar","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"2024060717234293300_djae019-B65","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00520-017-3965-4","article-title":"Racial differences in symptom management experiences during breast cancer treatment","volume":"26","author":"Samuel","year":"2018","journal-title":"Support Care Cancer"},{"issue":"7","key":"2024060717234293300_djae019-B66","doi-asserted-by":"publisher","first-page":"e2222214","DOI":"10.1001\/jamanetworkopen.2022.22214","article-title":"Acceptance of simulated adult patients with Medicaid insurance seeking care in a cancer hospital for a new cancer diagnosis","volume":"5","author":"Marks","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2024060717234293300_djae019-B67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12609-020-00365-0","article-title":"Integrating biology and access to care in addressing breast cancer disparities: 25 years\u2019 research experience in the Carolina Breast Cancer Study","volume":"12","author":"Emerson","year":"2020","journal-title":"Curr Breast Cancer Rep"},{"issue":"1","key":"2024060717234293300_djae019-B68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SLA.0000000000004592","article-title":"Cascading consequences of systemic racism on public health","volume":"273","author":"Newman","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"2024060717234293300_djae019-B69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1158\/1055-9965.EPI-20-1038","article-title":"Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area redlining, lending bias, and breast cancer mortality","volume":"30","author":"Collin","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"year":"2022","author":"Johns Hopkins Bloomberg School of Public Health","key":"2024060717234293300_djae019-B70"},{"issue":"7","key":"2024060717234293300_djae019-B71","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/oncolo\/oyac069","article-title":"Developing a virtual equity hub: adapting the tumor board model for equity in cancer care","volume":"27","author":"Irwin","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"2024060717234293300_djae019-B72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/ijerph19020632","article-title":"Place is power: investing in communities as a systemic leverage point to reduce breast cancer disparities by race","volume":"19","author":"Lyons","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"2024060717234293300_djae019-B73","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/onco.13964","article-title":"Adherence to endocrine therapy and racial outcome disparities in breast cancer","volume":"26","author":"Reeder-Hayes","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"2024060717234293300_djae019-B74","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/1055-9965.EPI-10-0944","article-title":"Race-specific impact of natural history, mammography screening and adjuvant treatment on breast cancer mortality rates in the US","volume":"20","author":"van Ravesteyn","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djae019\/56730446\/djae019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/6\/902\/58166313\/djae019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/6\/902\/58166313\/djae019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T17:25:18Z","timestamp":1717781118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/6\/902\/7590851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,1,27]]},"published-print":{"date-parts":[[2024,6,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djae019","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,1,27]]}}}